Page last updated: 2024-09-04

wy 26703 and piperoxan

wy 26703 has been researched along with piperoxan in 1 studies

Compound Research Comparison

Studies
(wy 26703)
Trials
(wy 26703)
Recent Studies (post-2010)
(wy 26703)
Studies
(piperoxan)
Trials
(piperoxan)
Recent Studies (post-2010) (piperoxan)
110018524

Protein Interaction Comparison

ProteinTaxonomywy 26703 (IC50)piperoxan (IC50)
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.72
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.14
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.14
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.14
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.72
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.14
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.72

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kassarich, J; Lien, EL; Morrison, A; Sullivan, D1

Other Studies

1 other study(ies) available for wy 26703 and piperoxan

ArticleYear
Alpha-2-adrenergic control of prolactin release.
    Neuroendocrinology, 1986, Volume: 44, Issue:2

    Topics: Animals; Brimonidine Tartrate; Clonidine; Dose-Response Relationship, Drug; Female; Male; Piperoxan; Pregnancy; Prolactin; Quinolizines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine

1986